Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Alliance Grants

Université Laval

$40,000.00

New bioabsorbable metallic biomaterials and competitive fabrication processes for Global Health, including neurosurgery

EF 2024-25

Résumé
Vascular stenosis is a condition affecting several millions of people in the world, every year. Often, stents fabricated with AISI316L stainless steel or self-expanding Nitinol are used to open clogged arteries and restore the blood flow. Nevertheless, these materials are composed by elements (Cr, Ni) whose release is noxious locally and systemically, despite their resistance to corrosion. These "permanent" stents could also cause complications in pediatric patients, whose cerebral vessels are rapidly growing in size. To overcome all these problems, polymeric or metal degradable materials, also known as absorbable materials, have been explored: they have the advantage to degrade gradually and to disappear after that the lesion is healed. To innovate in this field, the proposed project proposes the validation of a new Fe-Mn-C based alloys, with suitable chemical composition, mechanical properties and degradation rate for cardiovascular and neurovascular applications. This alloy family shows so exceptional mechanical properties that their thickness can be reduced by 4, compared to present devices thickness, thus decreasing the restenosis risk. Additionally, NanoGrande has the potential to fabricate micro and mini-sized devices with their unique molecular additive manufacturing technology. The project objectives aim at: i) the development of advanced Fe-Mn-C based absorbable alloys, whose microstructure allows to reach adequate mechanical and corrosion behavior; ii) the development of appropriate procedures, by machining, extrusion and additive manufacturing, for the production of Fe-Mn-C- based alloys with tuned properties for biomedical applications; iii) the optimization of the alloy properties through microstructural, mechanical, and electrochemical characterization; iv) the assessment and validation of the alloy neurotoxicity through biological tests conducted by the zebrafish model. Ultimately, CG Bio and NanoGrande will lead the industrial translation of the project, to develop and manufacture biodegradable stents from the designed alloy families using the optimized bioabsorbable material developed from this study, for vascular and neurological applications.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
586272-2023
Name nom
Mantovani, Diego D
Department département
Génie des mines, métallurgie et matériaux
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
40000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1208
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Materials sciences
Area of application fr
Sciences des matériaux
Research subject code
2000
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Materials science and technology
Research subject fr
Science et technologie des matériaux
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
New bioabsorbable metallic biomaterials and competitive fabrication processes for Global Health, including neurosurgery
Keywords
alloys; biocompatibility; biomaterials; fabrication; materials science and technology; mechanical properties; medical devices; metal 3d-printing; molecular additive manufacture; thermomechanical treatment
Application summary
Vascular stenosis is a condition affecting several millions of people in the world, every year. Often, stents fabricated with AISI316L stainless steel or self-expanding Nitinol are used to open clogged arteries and restore the blood flow. Nevertheless, these materials are composed by elements (Cr, Ni) whose release is noxious locally and systemically, despite their resistance to corrosion. These "permanent" stents could also cause complications in pediatric patients, whose cerebral vessels are rapidly growing in size. To overcome all these problems, polymeric or metal degradable materials, also known as absorbable materials, have been explored: they have the advantage to degrade gradually and to disappear after that the lesion is healed. To innovate in this field, the proposed project proposes the validation of a new Fe-Mn-C based alloys, with suitable chemical composition, mechanical properties and degradation rate for cardiovascular and neurovascular applications. This alloy family shows so exceptional mechanical properties that their thickness can be reduced by 4, compared to present devices thickness, thus decreasing the restenosis risk. Additionally, NanoGrande has the potential to fabricate micro and mini-sized devices with their unique molecular additive manufacturing technology. The project objectives aim at: i) the development of advanced Fe-Mn-C based absorbable alloys, whose microstructure allows to reach adequate mechanical and corrosion behavior; ii) the development of appropriate procedures, by machining, extrusion and additive manufacturing, for the production of Fe-Mn-C- based alloys with tuned properties for biomedical applications; iii) the optimization of the alloy properties through microstructural, mechanical, and electrochemical characterization; iv) the assessment and validation of the alloy neurotoxicity through biological tests conducted by the zebrafish model. Ultimately, CG Bio and NanoGrande will lead the industrial translation of the project, to develop and manufacture biodegradable stents from the designed alloy families using the optimized bioabsorbable material developed from this study, for vascular and neurological applications.